SE460702B - Lyofiliserad beredning av en beta-laktam stabiliserad med socker eller sockeralkoholfoerening, samt foerfarande foer dess framstaellning - Google Patents

Lyofiliserad beredning av en beta-laktam stabiliserad med socker eller sockeralkoholfoerening, samt foerfarande foer dess framstaellning

Info

Publication number
SE460702B
SE460702B SE8103904A SE8103904A SE460702B SE 460702 B SE460702 B SE 460702B SE 8103904 A SE8103904 A SE 8103904A SE 8103904 A SE8103904 A SE 8103904A SE 460702 B SE460702 B SE 460702B
Authority
SE
Sweden
Prior art keywords
preparation
sugar
weight
antibacterial
mannitol
Prior art date
Application number
SE8103904A
Other languages
English (en)
Swedish (sv)
Other versions
SE8103904L (sv
Inventor
E Hirai
K Shima
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of SE8103904L publication Critical patent/SE8103904L/xx
Publication of SE460702B publication Critical patent/SE460702B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SE8103904A 1980-06-23 1981-06-22 Lyofiliserad beredning av en beta-laktam stabiliserad med socker eller sockeralkoholfoerening, samt foerfarande foer dess framstaellning SE460702B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (2)

Publication Number Publication Date
SE8103904L SE8103904L (sv) 1981-12-24
SE460702B true SE460702B (sv) 1989-11-13

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8103904A SE460702B (sv) 1980-06-23 1981-06-22 Lyofiliserad beredning av en beta-laktam stabiliserad med socker eller sockeralkoholfoerening, samt foerfarande foer dess framstaellning

Country Status (31)

Country Link
US (1) US4418058A (es)
JP (1) JPS5711909A (es)
KR (1) KR840000693B1 (es)
AR (1) AR230007A1 (es)
AT (1) AT380790B (es)
AU (1) AU541627B2 (es)
BE (1) BE889351A (es)
BG (1) BG37991A3 (es)
CA (1) CA1164801A (es)
CH (1) CH648210A5 (es)
CS (1) CS221835B2 (es)
DD (1) DD159879A5 (es)
DE (1) DE3124592A1 (es)
DK (1) DK158443C (es)
ES (1) ES8203887A1 (es)
FI (1) FI75490C (es)
FR (1) FR2484835A1 (es)
GB (1) GB2078737B (es)
GR (1) GR75646B (es)
HU (1) HU183494B (es)
IE (1) IE51331B1 (es)
IL (1) IL63136A (es)
IT (1) IT1144812B (es)
NL (1) NL191777C (es)
NO (1) NO156036C (es)
NZ (1) NZ197414A (es)
PT (1) PT73239B (es)
RO (1) RO82720B (es)
SE (1) SE460702B (es)
YU (1) YU44416B (es)
ZA (1) ZA814203B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
AU2001271037A1 (en) * 2000-07-13 2002-01-30 Daiichi Pharmaceutical Co., Ltd. Pharmaceutical compositions containing dds compounds
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
CA2906151A1 (en) 2013-03-15 2014-09-18 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
WO2015035376A2 (en) 2013-09-09 2015-03-12 Calixa Therapeutics, Inc. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (es) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
NO774315L (no) * 1976-12-17 1978-06-20 Scherico Ltd Fremgangsmaate ved fremstilling av antibiotiske formuleringer
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
DD159879A5 (de) 1983-04-13
IL63136A0 (en) 1981-09-13
JPS6364405B2 (es) 1988-12-12
FI811948L (fi) 1981-12-24
NO156036B (no) 1987-04-06
ES503283A0 (es) 1982-04-01
BE889351A (fr) 1981-10-16
ATA278881A (de) 1985-12-15
YU44416B (en) 1990-08-31
GB2078737A (en) 1982-01-13
PT73239B (en) 1982-07-22
ZA814203B (en) 1982-09-29
RO82720A (ro) 1984-05-23
NL8102943A (nl) 1982-01-18
IE811347L (en) 1981-12-23
AU7209781A (en) 1983-01-06
FR2484835B1 (es) 1983-07-01
FI75490B (fi) 1988-03-31
AT380790B (de) 1986-07-10
HU183494B (en) 1984-05-28
ES8203887A1 (es) 1982-04-01
NL191777C (nl) 1996-08-02
KR840000693B1 (ko) 1984-05-21
IL63136A (en) 1984-07-31
CS221835B2 (en) 1983-04-29
FR2484835A1 (fr) 1981-12-24
YU157381A (en) 1984-10-31
DK158443C (da) 1990-10-08
NZ197414A (en) 1984-10-19
AU541627B2 (en) 1985-01-17
DE3124592A1 (de) 1982-02-11
NO812090L (no) 1981-12-28
KR830005848A (ko) 1983-09-14
GR75646B (es) 1984-08-02
SE8103904L (sv) 1981-12-24
CA1164801A (en) 1984-04-03
RO82720B (ro) 1984-07-30
JPS5711909A (en) 1982-01-21
CH648210A5 (de) 1985-03-15
FI75490C (fi) 1988-07-11
IT8167863A0 (it) 1981-06-22
DE3124592C2 (es) 1990-12-20
NO156036C (no) 1987-07-15
DK274981A (da) 1981-12-24
NL191777B (nl) 1996-04-01
IE51331B1 (en) 1986-12-10
PT73239A (en) 1981-07-01
AR230007A1 (es) 1984-02-29
IT1144812B (it) 1986-10-29
GB2078737B (en) 1984-03-14
DK158443B (da) 1990-05-21
US4418058A (en) 1983-11-29
BG37991A3 (en) 1985-09-16

Similar Documents

Publication Publication Date Title
SE460702B (sv) Lyofiliserad beredning av en beta-laktam stabiliserad med socker eller sockeralkoholfoerening, samt foerfarande foer dess framstaellning
US11872214B2 (en) Formulations of Bendamustine
US20130210879A1 (en) Formulations of bendamustine
BR112015028124B1 (pt) Formulação estabilizada de pemetrexed
US20170128575A1 (en) Liquid pharmaceutical formulations of pemetrexed
CA1231896A (en) Stable antibacterial lyophilizate
US20180110822A1 (en) Stable liquid pharmaceutical compositions of bortezomib
CA2026516C (en) Injectable preparations containing cephalosporin medicament
US11752164B2 (en) Bortezomib compositions
ES2673290T3 (es) Soluciones farmacéuticas orales que contienen fosfato sódico de hidrocortisona
HU191538B (en) Process for producing pharmaceutical compositions containing acid additional salts of vinca-dimeres
SU1213973A3 (ru) Способ стабилизации антибактериальной щелочнометаллической соли 7В-(а-карбокси-а-арилацетамидо)-7 @ -метоксил-3-гетероциклотиометил-1-детиа-1-окса-3-цефем-4-карбоновой кислоты
JPH02124822A (ja) セファロスポリン含有注射用組成物

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8103904-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8103904-2

Format of ref document f/p: F